Laura Sutcliffe
Stock Analyst at Citi
(2.61)
# 2,956
Out of 5,124 analysts
512
Total ratings
50.8%
Success rate
1.2%
Average return
Main Sectors:
Stocks Rated by Laura Sutcliffe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: ANN Ansell Limited | Reiterated: Sell | $39.50 | $46.06 | -14.24% | 19 | Nov 9, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Reiterated: Buy | $31.00 | $13.76 | +125.29% | 43 | Nov 4, 2026 | |
| RMD ResMed | Reiterated: Hold | $240 → $270 | $235.74 | +14.53% | 16 | Nov 2, 2026 | |
| ASX: RMD ResMed Inc. | Reiterated: Hold | $34.00 → $38.50 | $34.24 | +12.44% | 27 | Oct 30, 2026 | |
| ASX: CSL CSL Limited | Reiterated: Hold | $180.00 | $201.15 | -10.51% | 47 | Oct 25, 2026 | |
| NZE: EBO EBOS Group Limited | Reiterated: Buy | $28.00 → $27.38 | $21.39 | +27.99% | 8 | Oct 22, 2026 | |
| ASX: COH Cochlear Limited | Reiterated: Hold | $140.00 | $150.43 | -6.93% | 19 | Oct 19, 2026 | |
| ASX: PME Pro Medicus Limited | Reiterated: Buy | $225.00 | $205.02 | +9.75% | 9 | Sep 23, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Reiterated: Hold | $49.00 | $55.47 | -11.66% | 18 | Sep 10, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Reiterated: Hold | $22.00 | $19.92 | +10.44% | 17 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $51.00 | $48.30 | +5.59% | 9 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €40.00 → €34.00 | €29.86 | n/a | 14 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 86.00 → CHF 84.00 | CHF 133.46 | n/a | 61 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €118.00 → €103.00 | €85.76 | n/a | 56 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $12.46 | n/a | 1 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | 1,850p → 1,820p | 1,905p | n/a | 85 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $55.80 | n/a | 1 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $163.69 | n/a | 3 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $390 | $962.27 | n/a | 1 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $84 → $86 | $33.52 | n/a | 5 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €108.00 | €149.20 | n/a | 1 | Feb 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $48.12 | n/a | 1 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $51.54 | n/a | 1 | Feb 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $303 → $300 | $41.38 | n/a | 2 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $96 → $99 | $1,411.95 | n/a | 18 | Jul 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $55 | $62.14 | n/a | 16 | Oct 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $96 | $169.32 | n/a | 14 | Oct 18, 2017 |
Ansell Limited
Nov 9, 2026
Reiterated: Sell
Price Target: $39.50
Current: $46.06
Upside: -14.24%
Telix Pharmaceuticals Limited
Nov 4, 2026
Reiterated: Buy
Price Target: $31.00
Current: $13.76
Upside: +125.29%
ResMed
Nov 2, 2026
Reiterated: Hold
Price Target: $240 → $270
Current: $235.74
Upside: +14.53%
ResMed Inc.
Oct 30, 2026
Reiterated: Hold
Price Target: $34.00 → $38.50
Current: $34.24
Upside: +12.44%
CSL Limited
Oct 25, 2026
Reiterated: Hold
Price Target: $180.00
Current: $201.15
Upside: -10.51%
EBOS Group Limited
Oct 22, 2026
Reiterated: Buy
Price Target: $28.00 → $27.38
Current: $21.39
Upside: +27.99%
Cochlear Limited
Oct 19, 2026
Reiterated: Hold
Price Target: $140.00
Current: $150.43
Upside: -6.93%
Pro Medicus Limited
Sep 23, 2026
Reiterated: Buy
Price Target: $225.00
Current: $205.02
Upside: +9.75%
Ramsay Health Care Limited
Sep 10, 2026
Reiterated: Hold
Price Target: $49.00
Current: $55.47
Upside: -11.66%
Sonic Healthcare Limited
Sep 10, 2026
Reiterated: Hold
Price Target: $22.00
Current: $19.92
Upside: +10.44%
Sep 10, 2026
Upgraded: Buy
Price Target: $51.00
Current: $48.30
Upside: +5.59%
May 7, 2024
Reiterated: Hold
Price Target: €40.00 → €34.00
Current: €29.86
Upside: n/a
Dec 14, 2022
Reiterated: Hold
Price Target: CHF 86.00 → CHF 84.00
Current: CHF 133.46
Upside: n/a
Aug 9, 2022
Downgraded: Hold
Price Target: €118.00 → €103.00
Current: €85.76
Upside: n/a
Aug 9, 2022
Downgraded: Hold
Price Target: n/a
Current: $12.46
Upside: n/a
Aug 8, 2022
Reiterated: Hold
Price Target: 1,850p → 1,820p
Current: 1,905p
Upside: n/a
Mar 16, 2022
Upgraded: Buy
Price Target: n/a
Current: $55.80
Upside: n/a
Nov 5, 2021
Downgraded: Hold
Price Target: n/a
Current: $163.69
Upside: n/a
Jun 18, 2021
Initiated Coverage: Buy
Price Target: $390
Current: $962.27
Upside: n/a
Apr 12, 2021
Reiterated: Hold
Price Target: $84 → $86
Current: $33.52
Upside: n/a
Feb 28, 2020
Reiterated: Hold
Price Target: €108.00
Current: €149.20
Upside: n/a
Aug 14, 2019
Upgraded: Buy
Price Target: n/a
Current: $48.12
Upside: n/a
Feb 22, 2019
Downgraded: Hold
Price Target: n/a
Current: $51.54
Upside: n/a
Aug 8, 2018
Reiterated: Hold
Price Target: $303 → $300
Current: $41.38
Upside: n/a
Jul 25, 2018
Downgraded: Hold
Price Target: $96 → $99
Current: $1,411.95
Upside: n/a
Oct 26, 2017
Rated: Hold
Price Target: $55
Current: $62.14
Upside: n/a
Oct 18, 2017
Rated: Buy
Price Target: $96
Current: $169.32
Upside: n/a